Загрузка...
Efficacy of long-acting, injectable versus oral naltrexone for preventing admissions for alcohol use disorder
INTRODUCTION: Approximately 17 million Americans and 300 000 veterans have an alcohol use disorder (AUD). Both oral naltrexone (NTX) and long-acting, injectable naltrexone (LAI NTX) are FDA-approved to treat AUD. LAI NTX is often reserved for patients with adherence concerns due to considerable diff...
Сохранить в:
| Опубликовано в: : | Ment Health Clin |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
College of Psychiatric & Neurologic Pharmacists
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007564/ https://ncbi.nlm.nih.gov/pubmed/29955507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2017.05.106 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|